Clinical Trial Update: Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine [Phase 1]

View source ↗

Summary

This document provides a Phase 1 safety update on the recombinant GMZ2 malaria vaccine (GLURP + MSP3); the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• GMZ2 [GLURP + MSP3] Blood Stage Malaria Vaccine

Snippet

Sponsor: African Malaria Network Trust | Conditions: Malaria | Phase 1 | Status: UNKNOWN